Responsible supply base
We collaborate with suppliers that not only provide high quality products and services but also share our commitment to social, economic and environmental responsibilities as outlined in our Responsibility Standards for Suppliers.
Turning our supplier spend into societal good
Johnson & Johnson’s Global Supplier Diversity & Inclusion team is stepping up spending with social enterprises around the world to deepen its impact in local communities.
Overview
Our suppliers help us fulfill our mission to help transform healthcare with innovative supplier solutions.
Sustainability
Leveraging our resources and working with our suppliers to drive environmental improvements.
Supplier diversity
and inclusion
Increasing the breadth of our supplier base to innovate for our patients and deepen our connection to our communities around the world.
Health for Humanity and ESG
2023 Health for Humanity Report
Our extended supply chain comprises more than 38,500 suppliers supporting the development and manufacturing of our products worldwide.
ESG resources
As a purpose-driven company, how we deliver enduring impact is embedded in our business strategy through execution of our ESG strategy, which frames our ambitions, informs our operations and creates accountability for our vision of the future.
Additional policies and resources
Our Credo
The values that guide our decision-making are spelled out in Our Credo. Put simply, Our Credo challenges us to put the needs and well-being of the people we serve first.
Robert Wood Johnson, former chairman from 1932 to 1963 and a member of the Company’s founding family, crafted Our Credo himself in 1943, just before Johnson & Johnson became a publicly traded company. This was long before anyone ever heard the term “corporate social responsibility.” Our Credo is more than just a moral compass. We believe it’s a recipe for business success. The fact that Johnson & Johnson is one of only a handful of companies that have flourished through more than a century of change is proof of that.
Robert Wood Johnson, former chairman from 1932 to 1963 and a member of the Company’s founding family, crafted Our Credo himself in 1943, just before Johnson & Johnson became a publicly traded company. This was long before anyone ever heard the term “corporate social responsibility.” Our Credo is more than just a moral compass. We believe it’s a recipe for business success. The fact that Johnson & Johnson is one of only a handful of companies that have flourished through more than a century of change is proof of that.
More from Johnson & Johnson
This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others
Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.
After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists
Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.
How Johnson & Johnson is working to get medications to people around the world who need them most
In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.